Suspension of trading

PetIQ, Inc. Share Price

PETQ

US71639T1060

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 01:30:00 25/10/2024 am IST			5-day change	1st Jan Change
30.98 ^USD	-0.03%		-.--%	-

11/25/11	PetIQ, Inc. Announces CEO Changes	CI
25/24/25	PetIQ Says It Has Been Acquired by Bansk Group for $1.5 Billion	MT

Analysts' recommendations: PetIQ, Inc.

08/24/08	Benchmark Downgrades PetIQ to Hold From Buy, Price Target is $30	MT
08/24/08	Truist Downgrades PetIQ to Hold From Buy, Lifts Price Target to $31 From $30 Amid Bansk Group Deal	MT
07/24/07	Lake Street Downgrades PetIQ to Hold From Buy, Adjusts PT to $31 From $28	MT
07/24/07	William Blair Downgrades PetIQ to Market Perform From Outperform	MT
02/23/02	Truist Securities Raises PetIQ's Price Target to $30 From $25, Keeps Buy Rating	MT

More recommendations

Managers and Directors: PetIQ, Inc.

Manager	Title	Age	Since
Camillo Pane CEO	Chief Executive Officer	55	17/02/2025
Michael Smith PSD	President	48	01/06/2022
Zvi Glasman DFI	Director of Finance/CFO	62	03/01/2022

Director	Title	Age	Since
Lambertus Becht BRD	Director/Board Member	70	25/10/2024
Christopher Kelly BRD	Director/Board Member	-	25/10/2024
Timothy Stone BRD	Director/Board Member	-	25/10/2024

More insiders

PetIQ, Inc. is a pet medication and wellness company, which provides veterinary products and services. The Company operates through two segments: Products and Services. Products segment manufactures and distributes pet medication and health and wellness products to major United States retail and e-commerce channels through more than 60,000 points of distribution. It is focused its offerings on value-branded products, and third-party branded products for dogs and cats, including pet Rx medications, OTC medications, and wellness products. Services segment provides a comprehensive suite of services at approximately 2,600 community clinic locations and wellness centers hosted at retailers across 39 states. The segmentâs services include diagnostic tests, vaccinations, prescription medications, microchipping, grooming and hygiene and wellness checks. The Rx pet medications products include flea and tick control, heartworm preventatives, arthritis, thyroid, and other specialty medications.

Employees

1,527

Sector

Pharmaceuticals

More about the company

Income Statement and Estimates

More financial data

The best tools reserved for subscribers to boost the performance of your investments!

Capitalization	92Cr 79Cr 74Cr 69Cr 127.87Cr 8.34TCr 137.57Cr 848.54Cr 334.59Cr 3.98TCr 344.7Cr 337.6Cr 15TCr	P/E ratio 2022	-5.58x	P/E ratio 2023	282x
Enterprise value	127.11Cr 109.58Cr 102.01Cr 95Cr 176.82Cr 12TCr 190.25Cr 1.17TCr 462.69Cr 5.5TCr 476.68Cr 466.86Cr 20TCr	EV / Sales 2022	0.69x	EV / Sales 2023	0.84x
Free-Float	91.62%	Yield 2022 *	-	Yield 2023	-

11/25/11	PetIQ Names Camillo Pane as Chief Executive Officer	GL
25/24/25	PetIQ : Announces Successful Completion of Acquisition by Bansk Group Form 8 K	PU
25/24/25	PetIQ, Inc. Announces Successful Completion of Acquisition by Bansk Group	AQ
23/24/23	PetIQ : Reports Merger Agreement with Bansk Group Approved by Stockholders and Anticipates a Closing Date of October 25, 2024 Form 8 K	PU
23/24/23	PetIQ, Inc. Announces Results of Special Meeting of Stockholders	AQ

3 years	9.08	31.06
5 years	6.66	46
10 years	6.66	46

Name		Varia. Jan 1.	Weight	AuM
CSIF (IE) MSCI USA SMALL CAP ESG LEADERS BLUE UCITS ETF B - USD		-.--%	0.03%	0 M€
SECTOR ROTATION ETF - USD		+0.85%	0%	2,091 M€

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
PETIQ, INC.	-0.03%	-.--%	-.--%	+180.87%	92Cr
ZOETIS INC.	-0.50%	-1.98%	-24.86%	-22.08%	5.49TCr
ELANCO ANIMAL HEALTH INCORPORATED	+1.45%	+4.52%	+104.08%	+93.61%	1.22TCr
BLUESTAR ADISSEO COMPANY	-0.55%	-1.43%	-23.90%	+3.46%	396.9Cr
VIRBAC	-2.24%	-2.65%	+13.50%	+30.22%	346.93Cr
JINYU BIO-TECHNOLOGY CO., LTD.	+3.53%	+1.21%	+172.60%	+70.64%	276.16Cr
VIMIAN GROUP AB	-3.94%	-8.81%	-25.67%	+0.07%	176.12Cr
PHIBRO ANIMAL HEALTH CORPORATION	+2.52%	+4.13%	+97.26%	+176.19%	166.47Cr
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD.	+0.90%	+1.26%	+8.86%	+2.39%	131.3Cr
VETOQUINOL SA	-1.06%	-1.98%	+24.74%	-5.39%	116.44Cr
Average	+0.01%	-0.08%	+34.66%	+53.00%	841.43Cr
Weighted average by Cap.	-0.15%	-0.76%	+5.81%	+8.30%

PetIQ, Inc. Share Price

Equities

PETQ

US71639T1060

Pharmaceuticals

Valuation: PetIQ, Inc.

Latest news: PetIQ, Inc.

Analysts' recommendations: PetIQ, Inc.

Press Releases: PetIQ, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: PetIQ, Inc.

ETFs: PetIQ, Inc.

Veterinary Drugs

Financials

Company Profile

Income Statement and Estimates

	2022	2023
Net sales	92Cr 79Cr 74Cr 69Cr 128.19Cr 8.36TCr 137.92Cr 850.7Cr 335.44Cr 3.99TCr 345.58Cr 338.46Cr 15TCr	110.2Cr 95Cr 88Cr 82Cr 153.29Cr 10TCr 164.93Cr 1.02TCr 401.13Cr 4.77TCr 413.25Cr 404.74Cr 17TCr
Net income	-4.82Cr -4.16Cr -3.87Cr -3.6Cr -6.71Cr -437.41Cr -7.22Cr -45Cr -18Cr -208.64Cr -18Cr -18Cr -761.85Cr	21.31L 18.37L 17.1L 15.92L 29.64L 19Cr 31.89L 1.97Cr 77.57L 9.22Cr 79.91L 78.27L 34Cr
Net Debt	37Cr 32Cr 30Cr 28Cr 52Cr 3.36TCr 55Cr 342.19Cr 134.93Cr 1.6TCr 139Cr 136.14Cr 5.86TCr	35Cr 30Cr 28Cr 26Cr 49Cr 3.19TCr 53Cr 324.89Cr 128.11Cr 1.52TCr 131.98Cr 129.26Cr 5.56TCr